Revista de Gastroenterología del Perú - Volumen 17, Suplemento Nº1 1997

 

BIBLIOGRAFÍA 

 

1 . GENTA, R.M. Global prevalence of strongyloidiasis: critical review with epidemiologic insights in to the prevention of disseminated disease. Rev. Infect. Dis. 1989, 11: 755 - 767. 

2. MCRURY, JONNA et al. Specific IgE Responses in human strongyloidiasis. Clinical Experimental immunology. 1986; 65: 631 - 638. 

3. LEIGHTON P.M., MAC SWEEN H.M. Strongyloides stercoralis: the cause of an urticarial - like eruption of 65 years duration. Arch. Intern. Med. 1990; 150: 1747 -8. 

4. GENTA R. M. Strongyloides stercoralis, Inmunobiological Considerations on an unsual worm. Parásitology today. 1986; 2: 241 - 246. 

5. GENTA R.M., HELLMAN M.E. and SCHAD G.A. Strongyloidesstercoralis: Parasitological, immunological and pathological observations in immunosuppressed dogs. Transactions of the Royal Society of Tropical Medicine and Hygiene. 1986, 80: 34 - 41. 

6. LIMA J.P. and DELGADO J.P. Diagnosis of strongyloidiasis: importance of Baermann's method. Am J. Dig. Dis. 1961, 6: 899 - 903. 

7. MAHMOUDAAF Intestinal Nematodes. En: Mandell G.L. de. Principles and practice of infectious disease. New York: Churchill Livingstone, 1990; 2139 - 40. 

8. NAQUIRA C., JIMENEZ G., GUERRA J. et al. Ivermectine for human strongyloidiasis and other intestinal Helminths. Am J. Trop. Med. 1989.40 (3) 304 -309. 

9. ARCHIBALD L.K., BEECHING N.I. GILL G.V. et al. Albendazol is effective treatment for chronic strongyloidiasis. Q.J. Med. 1993; 86: 191 - 195. 

10. CAHILL K.M. Thiabendazol in mássive Strongyloidiasis. Am J. Trop. Med. Hyg., 1967; 16: 451 - 455.

11. LUMBRERAS H., MUF40Z N. Strongyloidiasis en el Per6; Incidencia en la ciudad de Pucallpa, seg6n la t6cnica de Baerman modificada en Copa. Rev. Med . Per. 1963, 32: 127 - 133.

12. CORNEJO D. Y Col. Parasitismo en la carretera Marginal de la Selva. Departamento de San Martín. IV Congreso Latinoamericano de Microbiología y Parasitología. 26 nov. - 2 dic, Lima 1967.

13. PALOMINO B. Balantidiasis y strongyloidiasis en Tingo Maria y sus alrededores. Uso de la Técnica de Baerman modificada en Copa. Tesis Br. Med. UPCH 1972, Lima - Per6.

14. BENITO G. Balantidiasis y strongyloidiasis en Iquitos. Uso de la Técnica de Baerman modificada en Copa. Tesis Br. Med. UPCH 1975, Lima -PerO.

15. ZAVALA J., SANCHEZ L., CARRILLO L. y Col. Presentaciones atípicas de strongyloidiasis: Reporte de 8 casos. Rev. Gastroent. Pen) 1994, 14: 15 -21. 

16. CROSS J.H. Parasites of small intestine, en Gastrointestinal and Hepatic Infectious. C. Surawicz and R. Owen (eds,). W.B. Sannders Company. Philadelphia 1995. 

17. FAUST E., RUSSELL P. Y JUNG R. Parasitología. Médica 1° edición 1975. Salvat Editores. 

18. NEVA F. Biology and Immunology of human strongyloidiasis. J. Infect. Dis. 1986. 153: 397 - 406. 

19. LONGWORTH D.L., WELLER D. Hyperinfection syndrome with strongyloidiasis. En Current Clinical Topics in infectious diseases. New York, 1986 vol. 7: 1 -26. 

20. SCOWDEN E.B., SCHAFFNER W. y STONE W.J. Overwhelming strongyloidiasis: an unappreciated oportunistic infection. En: Medicine 1978; 57(6): 527 -544. 

21. SCHAD G.A., AIKENS L.M., SMITH G. Strongyloides stercoralis: is more a canonical migratory route through the host?. J. Parásitol. 1989, 75: 740 - 9. 

22. GROVE D.I. Strongyloidiasis: a conundrum for gastroenterogists GUT 1994; 35: 437 - 440. 

23. CHATTERJEE K.D. Parásitology, protozoology and helmintology 11° ed. Calcuta: S.N.Guha Ray at Sree Saraswaty Press Ltd, 1977. 237.

24. BOTERO D., RESTREPO M. Parasitosis humanas: Parasitosis lnstestinales por Nematodos 2°ed. Medellin: Clb., 1992. 418.

25. WARREN K.S., MAHMOUD AAF eds. Tropical and geographical medicine. 21ed. New York. Mc. Graw Hill Information Services. 1990.

26. GIANNELLA R.A., BROITMAN S.A., ZAMCHECK N. Influence of gastric acidity on bacterial and parasitic enteric infectious. Ann Intern Med. 1973, 11: 267 - 72.

27. DEVAULT G. et al. Oportunistic infectious with in renal transplantation. EN: Reviews of infectious diseases. 1990, 12 (4): 653 - 671.

28. RAMELLI D. Hallazgos clínico-patológicos en trece casos de strongyloidiasis fatal en Cali. Acta Médica del Valle. Cali 1973, 4: 38 - 43.

29. SANDOSHAM A.A. Investigation into the association of creeping eruption with strongyloides infection contracted in the Far east. J. Helminthol 1952; 26: 1 -24.

30. SMITH J.D., GOETTE D.K., ODOM R.S. Larvacurrens. Cutaneus strongyloidiasis. Arch. Dermatol. 1976; 112: 1161-3.

31. WORLD HEALTH ORGANIZATION. Scientific Group on Intestinal Protozoan and Helmintic Infectious. Epidemiology and Laboratory diagnosis of human strongyloidiasis. Ginebra 1980. 5p.

32. BRAS G. et al. Infection with Strongyloides stercoralis in Jamaica. The Lancet 1964, 2(12): 1257 - 1260.

33. LIU L.X, WELLER P.F. Strongyloidiasis and other intestinal nematode infections. Infectious Disease Clinics of North America 1993, 7(3): 655 - 682.

34. SPROTT V., SELBY C.D., ISPANAMI P. et al. Indigenous strongyloidiasis in Nottingham. BMJ, 1987, 294: 741.

35. DAVIDSON R.A. Strongyloidiasis. A presentation of 63 cases. North Carolina Med. J. 1982, 42: 23.

36. HINMAM E.H. A study of 85 cases of strongyloidiasis with special reference to abdominal pain. Trans. R. Soc. Trop. Med. Hyg, 1937, 30: 340 - 45.

37. ELLIOT A., CACERES I. Introducción a la Parásitología

Médica del Perú. 1° ed. 1988. pp. 43 - 46.

38. PAWLOWSKI Z.S. Epidemiology, prevention, control. In. Group D.I. ed. Strogyloidiasis: a major roundworm infection of man. Londom: Taylor & Francis 1989; 233 - 49.

39. GROVE D.I. Strongyloidiasis: is it transmitted from husband to wife?. Por J. Vener Dis. 1982; 58: 271 - 2.

40. CARVALHO FILHO E. Strogyloidiasis En: Clinics in Gastroenterology 1978 7 (1): 179 - 200.

41. BRAUN T.I., FEKETE T., LYNCH A. Strongyloidiasis in an institution for mentally retarded adults. Arch. Intern Med. 1988; 148: 634. 

42. YOELI M., MOST H., HAMMOND J. et al. The problem of strongyloidiasis among mentally retarded in Institutions. Trans. R. Soc. Trop. Med. Hyg. 1963; 57: 336-341. 

43. YOELI M., MOST H., HAMMOND J. et al. Parasitic infections in a closed community. Results of 10 years survey in willowbrook state school. Trans. R. Soc. Trop. Med. Hyg. 1972; 66: 764 - 69. 

44. GENTA R.M., WARD P.A. The Histopathology of experimental strongyloidiasis. Journal of Pathology. 1980; 99(1): 207 - 213. 

45. DE PAOLA D., DIAS L.B. DA SILVA J.R. Enteritis due to strogyloides stercoralis: a report of five fatal cases. J. of Digest Dis. 1962; 7: 1086 - 1098. 

46. HANSON P. Tropical Diseases, a manual of diseases of warm climates. 6° de. New York. William Wood and Company. 1919. 968 p. 

47. MASDEU J. Et al Brain abcess caused by Strongyloides stercoralis. Archives of neurology 1982, 39: 62 - 63. 

48. GENTA R.M. et al Opportunistic Strongyloides stercoralis infection in Lynphoma patients: report of a case and review of the literature Cancer, 1989, 63: 1407-1411. 

49. ONUIGBO M.A.C., IBEACHUM G.I. Strongyloides stercoralis larvae in peripheral blood. Trans. R. Soc. Trop. Med. And Hyg. 1991, 85: 97. 

50. SCHAD G.A., SMITH G., MEGYERI Z., et al Strongyloides stercoralis: an initial autoinfective burst amplifies primary infection, 1993J. Trop. Med. Hyg. 48: 716-725. 

51. IGRA-SIEGMAN Y., KAPICAR., SEN P.etal Syndrome of hyperinfection with Strogyloides stercoralis; Rev. Infect. Dis. 1981, 3: 397 - 407. 

52. GALLIARD H. La strongyloidose humaine mortalle. Ann Fae. Med. Phams. 1942, 7: 83 - 94. 

53. GALLIARD H. Recherches sur L'infectation experimentale a Strongyloides; stercoralis an Tonkin Ann Parásitol, 1950 XXV: 441 - 473. 

54. GALLIARD H. And BERDONNEAU R. Strongyloidose experimentale dug le clien. Effects de la cortisone. Resultats du test de Thorn a L'Hormone corticotrope (ACTH). Ann Parásitol 1953, 23: 163 - 171. 

55. SCHAD G.A. Natural control of the abundance of parasitic helminths. Bull. Indian Soc. Malar. Commun. Dis. 1966, 3:18 - 27. 

56. ANDERSON R.M. The population dynamics and epidemiology of intestinal nematode infections. Trans. R. Soc. Trop. Med. Hyg. 1986, 80: 686 - 696.

57. GENTA R. Dysregulation of strongyloidiasis: A new hypothesis. Clinical Microbiology Reviews 1992, 5: 345-355. 

58. GENTA R. And CAYMMI-GONES M. Pathology in D.A. Grove (ed) strongyloidiasis a major roundworm infection of man. Taylor & Francis, London, 1989,105 -132. 

59. GENTA R. And GROVE D:I: Strogyliodes stercoralis infections in animals in D.A. Grove (ed) strogyloidiasis a major roundworm infection of man. Taylor & Francis London, 1989, 251 - 269. 

60. WEST B.C. and WILSON J.P. Subconjuntival corticosteroid therapy complicated by hyperinfective strongyloidiasis. Am. J. Ophtalmol, 1980,89:854-857. 

61. HERNDON F.J., KAYES S.G. Depletion of eosinophils by anti-IL5 monoclonal antibody treatment of mice infected with Trichinella spiralis does not alter parasite burden or immunologic resistance to reinfection. J. Immunol., 1992, 149: 3642 - 3648. 

62. SHER A., COTTMAN R.L., HIENY S. et al Ablation of eosinophils and IgE responseswith anti-IL5 or anti-IL4 antibodies fails to affect immunity against Schistosoma mansoni in the mouse. J. Immunol., 1990, 145: 3911 -3916. 

63. GENTA R.M., et al. Prominence of IgG4 antibodies in the human responses to Strongyloides stercoralis infection. J. Infect Dis., 1989, 160: 692 - 698. 

64. GENTAR.M. Immunobiology of strogyloidiasis. Trop. Geogr. Med., 1984, 34: 223 - 227. 

65. FINKELMANN F.D., PEARCE E.J., URBAN J.F. et al Regulation and biological function of helmintes- induced cytokines. response. Parásitology Today, 1991, 7: 162. 

66. SHER A., COFFMAN R.L. Regulation of immunity to parasite G y T cell and T cell-derived cytokines. Am Rev. Immunol. 1990; 10: 385 - 90. 

67. URBAN J.F., MADDEN K.B., SVETIC A. et al: The importance of The cytokines; in protective immunity to nematodes. Immunol. Rev. 1992; 127: 206 - 211. 

68. PRITCHARD D.I., Immunity to helminths: Is too much IgE parasite valber than host-protective?. Parasite Immunol. 1993, 15: 5 - 11. 

69. BRIGANDI R.A., ROTMAN H.I., NOLAN T.I. et al Chronicity in Strongyloides stercoralis infections: Dichotomy of the protective immune response to infective and autoinfective larvae in a mouse model. Am J. Trop. Med. Hyg. 1997, 56(6): 640 - 646.

70. HARPER J.S., GENTA R., GAM A.A., et al Experimental disseminated strongyloidiasis in erythrocebus patos I Pathology. Am J. Trop. Med. Hyg. 1984,33:431 - 433. 

71. SCHAD G.A., HELLMAN M.E., MUNLEY A.W. Strongyloides stercoralis: hyperinfection 'in immnosupressed dogs Exp. Parásitol., 1984; 57: 287 296. 

72. BADARO R., CARVALHO E.M., SANTOS R.B. et al Parasite-specific humoral responses in different clinical forms of strongyloidiasis. Trans. R. Soc. Trop. Med. Hyg. 1987; 81:149 - 150. 

73. DE MESSIAS I.T., TELLES F.Q., BOARETTI A.C. et al Clinical immunological and epidemiological aspects of strogyloidiasis in an endemic area of Brazil Allergol Immunopathol 1987; 15: 37 - 41. 

74. DATE A.K., VASKA P.H., VASKA A.P. et al Terminal infections in renal transplant patients in a tropical enviroment. Naphron. 1982; 32: 253 - 257. 

75. DOUCE R.W:, BROWN A:E:, KHAMBOGRUANG P.D. et al Sero epidemiology of strongyloidiasis in a the Village. Int. J. Parásitol 1987; 17: 1343 - 1348. 

76. SCHAD G.A. Cyclosporine may aliminate the threat of overwhelming strogyloidiasis in immunosuppressed patients (letter). J. Infect. Dis. 1986; 153: 178. 

77. MOURA H., FERNANDEZO., VIOLAJ.P., et al Enteric parasitesand HIV infection occurrence in AIDS patients in Rio de Janeiro. Brazil Memo. Inst. Oswaldo Cruz 1989; 84: 527 - 533. 

78. FUJITA K., TAJIMA K., TOMINAGA S. et al Seroepiderniological studies on strongyloides infection in aduItT-cell leukemia virus carriers in Okinawa Island, Japan. Trop. Med. 1985; 27: 203 - 209. 

79. NAKADA K., YAMAGUCHI K., FURUGEN S. et al Monoclonal integration of HTLV-1 proviral DNA in patients with strogyloidiasis. Int. J. Cancer 1987; 40: 145-148. 

80. NEVA F.A., MURPHY E.L., HANCHARD B. et al Antibodies to Strongyloides stercoralis in healthy Jamaica carriers of HTLV-1 (letter). N. Engl. J. Med., 1989; 320: 252 - 253.

 

81. DE VAULT G.A., BROWN S.T., MONTOYA S.F. et al Disseminated strongyloidiasis complicating acute renal allograft rejection. Transplantation 1989; 34: 220 -221. 

82. GENTA R., MILES P., FIELDS K. Opportunistic Strongyloides stercoralis infection in Lymphoma patients. Report of a case and review of the literature. Cancer 1989; 63: 1407 - 1411. 

83. HARRIS R.A., MUSHER D.M., FAINSTEIN V. et al, Disseminated strongyloidiasis. Diagnosis made by sputum examination. JAMA, 1980; 244: 65 - 66. 

84. RIVERA E., MALDONADO N., VELEZ-GARCIA E. etal Hyperinfection syndrome with Strongyloidesstercoralis. Ann Intern Med. 1970; 72: 199 - 204. 

85. HANDLER A.H. and MAROY P.Ecclysteroid receptors in Drosophila melanogaster. Mol. Cell. Enclocrinol., 1989; 63: 103 - 109. 

86. KOOLMAN J., WALTER J., ZAHNER H. Ecclysteroids in helminths. In J. Hoffmann and M. Porcher (ed.). Metabolism and mode of action of invertebrate hormones. Springer-Verlog, Berlin. 1984. 

87. CUMMINS R.O., SURAT P.M., HORWITZ D.A. Disseminated Strongyloides stercoralis infection. Association with ectopicACTH syndrome and depressed cell-mediated immunity. Arch. Intern. Med. 1978; 138: 1005-1006. 

88. VON KUSTER L., GENTA R. Cutaneous manifestations of strogyloidiasis. Arch. of Dermat. 1988; 124: 1826 -1830. 

89. KALB R.E., GROSSMAN M.E. Periumbilical purpura. in clesserninated strogyloidiasis. JAMA, 1986; 256:1170 -1171. 

90. CHAUDHARY K., SMITH R.J. HIMELRIGHT I.M. et al Case Report: Purpura in clesserninated strongyloidiasis. Am J. Med. Sa. 1994; 308: 186 - 19 1. 

91. RONAN S.G., READY R.L., MANALIGOID J.R. et al Disseminated strongyloicliclasis presenting as purpura. J. Am. Acad. Dermatol. 1989; 21: 1123 - 25. 

92. SHIROMA Y. Studies on human strongyloicliasis on Okinawa, Ryukyu - Kagoshima Med. J. 1964; 34: 243 -246. 

93. Case Records of the Mássachussets General Hospital (case 13-1986). N. Engl. J. Med. 1986; 314: 903 - 910 

94. MILNER P.F., IRVING R.A., BARTON C.J. etal Intestinal malabsortion in Strongyloides stercoralis infection. GUT. 1965; 6: 574 - 579. 

95. O'BRIEN W. Intestinal malabsortion in acute infection with Strogyloides stercoralis. Trans. R. Soc. Trop. Med. Hyg. 1975; 69: 69 - 75. 

96. ODDO D., DUARTE Y. Síndrome cle malabsorci6n por strongyloides stercoralis. Caso cle autopsia. Rev. Med. Chile 1983; 111: 443 - 446. 

97. LOUISYC.L., BARTON C.J. Theradiological diagnosis of Strongyloides stercoralis enteritis. Radiology, 1971; 98: 535 - 541. 

98. SALAZAR R., MENDOZA R., GUTIERREZ L., MORI R. Síndrome edematoso y suboclusión intestinal por Strongyloides stercoralis. Diagnóstico, 1985; 15(4): 105-109. 

99. BERKMEN Y.M., RABINOWITZ J. Gastrointestinal manifestations of strongyloidiasis. Am J. Roentgenol ther Nud. Med., 1972; 115: 306 - 310. 

100. BRASITUST.A., GOLD R.P., KAY R.H. etal Intestinal strongyloidiasis: A case report and review of the literature. Am J. Gastroenterol., 1980; 73: 65 - 67.

101. DALLEMAND S., WAXMAN M., FARNAN J. Radiological manifestations of Strongyloides stercoralis. Gastrointestinal Radiol., 1983; 8: 45 - 49. 

102. BURKE J.A. Strongyloidiasis in chilhood. Am J. Dis. Child. 1978; 132:1130 - 1136. 

103. STONE J.O., GORDON B.N., MULLINS F. Cutaneous strongyloidiasis: larva currens. Arch. Derm., 1972; 106: 734 - 736. 

104. ARTHUR R., SHELLEYW. Larvacurrens. Arch. Derm., 1958; 78: 185 - 190. 

105. SMITH J.D., GOETTE D.K., ODOM R.B. Larvacurrens: cutaneous strongyloidiasis. Arch. Derm., 1976; 112: 1161 -1163. 

106. PIERCE JJ., DYER E.L. Extreme eosinophilia and strongyloidiasis: An uncommon manifestation of a common disease. South Med. J., 1981; 74: 995 - 998. 

107. DAVIDSON R.A., FLETCHER R.H., CHAPMAN L.E. Risk factors for strongyloidiasis. A case. Control study. Arch. Intern. Med., 1984; 144: 321 - 324. 

108. GROVE D.I. Clinical manifestations. In Grove D.I. (ed) Strongyloidiasis: A major roundworm infection of man. London, Taylor and Francis, 1989 p. 155. 

109. AINLEY C.C., CLARKE D.G., TIMOTHY A.R. et al. Strongyloides stercoralis hyperinfection associated with cimetidine in an immunosuppressed patient: diagnosis by endoscopic biopsy. GUT 1986; 27: 337 -338. 

110. WURTZ R., MIROT M., FRONDA G., et al. Short report: Gastric infection by strongyloides stercoralis. Am J. Trop. Med. Hyg., 1994; 51(3): 339 - 340. 

111. NUCCI M., PORTUGAL R., PULCHERI W. et al  Strongyloidiasis in patients with hematologic malignancies. Clin. Infect. Dis. 1995; 21: 675 - 677. 

112. PANSEGROUWD. Strongyloidesstercoralis infection másquerading as steroid resistant asthma. Monaldi Arch. Chest. Dis., 1994; 49(5): 399 - 402. 

113. SEN P., GIL C., ESTRELLAS B. et al. Corticosteroidinclucedasthma: a manifestation of limited hyperinfection syndrome due to Strongyloides stercoralis. South Med. J. 1995; 88(9): 923 - 927.

114. LEEMAN B.J., CABRERA M.R. No association found between strongyloides infestation and asthma. J. Asthma, 1995; 32(1): 57 - 62. 

115.SUELDO E. Manifestaciones clínicas en la strogyloidiasis. Contribución al estudio del síndrome de Hiperinfección (Tesis de Bachiller). Lima - Perú, Universidad Peruana Cayetano Heredia, 1987. 

116. POWELL R.W., MOSS J.P., NAGAR D. et al. Strongyloidiasis in immunosuppressed host. Presentation as mássive lower gastrointestinal bleeding. Arch. Intern Med., 1980; 140: 1061 - 1064. 

117. COOKSON J.B., MONTGOMERY R.D., MORGAN H.V et al. Fatal paralytic ileus due to strongyloidiasis. BMJ, 1972; 4: 771 - 3. 

118. CRAVEN J.L., CANTRELL E.G., LEWIS M.G. Strogyloides stercoralis infection presenting as necrotizing jejunitis. Trans. R. Soc. Trop. Med. Hyg., 1971; 65: 532 - 536. 

119. COOK G.A., RODRÍGUEZ H., SILVA H. et al. Adult respiratory distress secondary to strongyloidiasis. Chest, 1987; 92: 1115 - 17. 

120. DUNLAP N.E., SHIN M.S., POLT S.S. et al. Strongyloidiasis manifested as asthma. South Med. J., 1984; 77: 77 - 80. 

121. NWOKOLO C., IMOHIOSEN E.A. Strongyloidiasis of respiratory tract presenting as "asthma". BMJ, 1973; 2: 153-155. 

122. SMITH B., VERGHESE A., GUTIERREZ C:H. et al. Pulmonary strongyloidiasis. Diagnosis by sputum Gram stain. Am J. Med., 1985; 79: 663 - 666. 

123. CHAUDHURI B., NANOS S., SOCO J.N. et al. Disseminated strongyloides stercoralis infestation detected by sputum cytology. Acta Cytol., 1980; 24: 360-363. 

124. HARRIS R.A., MUSHER D.M., FAINSTEIN V. et al. Disseminated strongyloidiasis. Diagnosis made by sputum examination. JAMA, 1980; 244: 65 - 68.

125. TELLO R. et al. Examen de esputo empleando la técnica de Baermann para el diagnóstico de autoinfección por Strongyloides stercoralis. Libro de Resúmenes del V Congreso Panamericano de Infectología - 11 Congreso Peruano de Enfermedades Infecciosas y Tropicales. 1991, 11: 7. 

126. POLTERA A.A., KATSIMBURA N. Granulomatous hepatitis due to strongyloides stercoralis. J. Pathol., 1974; 113: 241 - 244. 

127. MELTZER R.S., SINGER C., ARMSTRONG D. et al. Antemortern diagnosis of central nervous system strongyloidiasis. Am J. Med. Sci., 1979; 277: 91 -93. 

128. NEEFE L.I., PINILLA 0., GARAGUSI V.F. et al. Disseminated strongyloidiasis with cerebral involvement. A complication of corticosteroid therapy. Am J. Med., 1973; 55: 832. 

129. ALI-KHAN Z.,SEEMAYER T.A. Fatal bowel infarction and sepsis: an unusual complication of systemic strongyloidiasis. Trans. R. Soc. Trop. Med. Hyg., 1975; 69: 473 - 476. 

130. DEL CARPIO D., RODRIGUEZ D., VILDOSOLA H. Síndrome de Hiperinfección por Strongyloides stercoralis en una paciente con infección por el virus de la inmunodeficiencia humana (VIH): Reporte de un caso y revisi6n de la literatura. Rev. De Gastroenterol. del Perú, 1995; 15: 290 - 295. 

131. SAVAGE D., FOADI M., HAWORTH C. et al. Marked eosinophilia in pn immunosuppressed patient with strongyloidiasis. J. of Intern. Med., 1994; 236: 473 -475. 

132. PANTALEO G., GRAZIOSI C., FAUCI A.S. The Immunopathogenesisof human immunodeficiency virus infection. N. Engl. J. Med., 1993; 328: 327 - 335. 

133. TORRES J.R., ISTURIZ R. et al. Eff icacy of Ivermectin in the treatment of strogyloidiasis complicating AIDS. Clin. Infect. Dis., 1993; 17: 900 - 902. 

134. PHILLIPS S.C., MILDVAN D., WILLIAM D.C. et al. Sexual transmission of enteric protozoo and helminths in a Venereal-disease-clinic population. N. Engl. J. Med., 1981; 305: 603 - 608. 

135. SORVILLO F., MORI K., SEWARE W. et al. Sexual transmission of Strongyloides stercoralis among homosexual men. British J. Venereal Diseases, 1983; 59: 342 - 346.

136.PETITHORY J.C., DEROUIN F.: AIDS and strongyloidiasis in Africa. Lancet, 1987; 1: 921. 

137. SOUZA RMDS, MANGINI ACS, TORRES DMAGU. et al. Ocurrencia de Strongyloides stercoralis en pacientes portadores da síndrome de imunodeficiencia adquirida (AIDS). Rev, Inst. Med. Trop. Sao Paulo, 1992; 34(l): 15 - 17. 

138. DUTCHER J.P., MARCUS S.L., TANOWITZ H.B. etal. Disseminated Strongyloidiasis with Central Nervus System involvement diagnosed antemorten in a patient with Acquiered Immunodeficiency Syndrome and Burkitts Lymphoma. Cancer, 1990; 60: 2417 - 2420. 

139. MAAYAN S., WORMSER G.L., SY E.R. et al. Strongyloides stercoralis Hyperinfection in a paatient with the Acquired Immune Deficiency Syndrome. Am J. Med., 1987; 83: 945 - 948. 

140.LESSNAU K.B., CAN S., TALAVERA W. Disseminated Strongyloides stercoralis in Human Immunodeficiency virus-infected patient. CHEST., 1993; 104: 119 - 122. 

141. GENTA R.M., DOUCE R.W., WALZER P.D. Diagnostic implications of parasite-specific immune responses in immunocompromised patients with strongyloidiasis. J. Clin. Microbiol., 1986; 23: 1099 - 1103.

142. GENTA R.M., LILLIBRIDGE J.P. Prominence of IgG4 antibodies in the human responses to Strongyloides stercoralis infection. J. Infect. Dis., 1989; 160: 692 -699. 

143. CELEDON J.C., MATHUR-WAGH U., FOX J. et al. Systemic strongyloidiasis in patients infected with the human immunodeficiency virus. A report of 3 cases and review of the literature. Medicine, 1994; 73(5):256 -262. 

144. POIESZ B.J., RUSCETTI F.W., GAZDAR A.F. et al. Detection and isolation of type C retrovirus particles from fresh and cultured Lymphocytes of a patient with cutaneous T-Cell lymphoma. Proc. Nafl. Acad. Sci., 1980; 77: 7415 - 7419. 

145. YOSHIDA M., MIYOSHI I., HINUMA Y. Isolation and characterization of retrovirus from cell lines of human aduItT-Cell leukemiaand its implication inthe diseases. Proc. Nafl. Acad. Sci., 1982; 79: 2031 - 2035. 

146. CLARK J.W., ROBERT-GUROFF M., IKEHARA 0. et al. Human T-Cell leukemia-lymphoma virus type I and adult T-Cell leukemia-lymphoma in Okinawa. Cacer Res., 1985; 45: 2849 - 2852. 

147. POPOVIC M., FLOMBERG N., VOLKMAN D.J. et al. Alteration of T-Cell function by infection with HTLV-1 or HTLV-11. Science, 1984; 226: 455 - 462. 

148. NEWTON R.C., LIMPUANGTHIP P., GREENBERG S. et al. Strongyloides stercoralis hyperinfection in a carrierof HTLV-I virus with evidence of selective immuno suppression. Am J. Med., 1992; 92: 202 - 208. 

149. NAKADA K., KOHAKURA M., KOMODA H. et al. High incidence of HTLV antibody carriers of Strongyloides stercoralis. The Lancet, 1984; 1: 633. 

150. SATO Y., SHIROMA Y. Concurrent infections with strongyloides andTCell leukemia virus and their possible effect on immune responses of host. Clin. Immunopathol., 1989; 52: 214 - 224. 

151. NEVA F.A., GAM A.A., BURKEJ. Comparison of larval antigens inan enzyme-linked immunosorbant assay for strongyloides in humans. J. Infect. Dis., 1989; 160:692 -699. 

152. HAVASHI J., KISHIHARA Y., YOSHIMURA E. et al. Correlation between human T-Cell Lymphotropic virus type I and Strongyloides stercoralis infections and serum immunoglobuline E responses in residents of Okinawa, Japan. Am J. Trop. Med. Hyg., 1997; 56 (1): 71 -75. 

153. GOTUZZO E., TERASHIMA A. et al. HTLV-1 en pacientes con autoinfestación por strongyloides. Libro de Resúmenes del IV Congreso Peruano de Enfermedades Infecciosas y Tropicales, 1995; R-27.

154. ZAHA O. Investigation of clinical symptoms in slight strongyloidiasis. J. Jap. Assoc. Infect Dis., 1992; 66: 1378-1381. 

155. HANADA S., VEMATSU T. The prevalence of human T-Cell leukemia virus type I infection in patients with hematologic and non hematologic diseases in an adult T-Cell leukemia-endemic area of Japan. Cancer, 1989; 64: 1290 - 1295. 

156. SATO Y., TOMA H. Seroepidemiological studies on the concomitance of strongyloidiasis with T-Cell leukemia viral infection in Okinawa, Japan. Jap. J. Parasitol., 1990; 39: 376 - 383. 

157. MATSUMOTO T., MIIKE T. Decreased serum levels of IgE and IgEbuilding factors in individuals infected with HTLV-I. Clin. Exp. Immunol., 1990; 81: 207 - 211. 

158. SHIDRAWI R.G., SHOUSHA S. and WESTABY D. Systemic strongyloidiasis in a human, T-lymphotropic virus type I-positive man presenting as chronic pancrealites with a pancreatitis-biliary stricture. Eur. J. Gastroenterol. and Hepatol., 1994; 6: 1059 - 1062.

159. SATO Y., SHIROMA Y., KIYUNA S. et al. Reduced efficacyof chemotherapy migth accumulate concurrent HTLV-I infection among strongyloidiasis patients in Okinawa, Japan. Trans. R. Trop. Med. Hyg., 1994; 88: 59. 

160. GENTA R. Strongyloidiasis. Bailliers Clinical Tropical Medicine and Communicable Disease, 1987; 2: 245 -654. 

161. NIELSEN P.B., MOJON M. Improved diagnosis of Strongyloides stercoralis by seven consecutive stool specimens. Zentralbl Bakterial Mikrobiol Hyg. (a) 1987; 263: 616. 

162. RAZON R., REYES B. Diagnóstico de Strogyloides stercoralis por el método de Baermann. Revista Cubana de Medicina Tropical, 1961; 3: 73 - 76. 

163. SATO Y., KOBAYASHI J., TOMA H. et al. Efficacy of stool axamination for detection of Strongyloides infection. Am J. Trop. Med. Hyg., 1995; 53 (3): 248 -250. 

164. BOTERO D., RESTREPO M. Estudio comparativo de 5 métodos para investigar parásitos en materias fecales. Antioquia Médica, 1959; 9: 285 - 295.

165. FERRIOLLI F. Condicoes que influema na extracao de larvas do Strongyloides stercoralis das fezes pelo método de Loos-Baermann modificado. Rev. Int. Med. Trop. Sao Paulo, 1961; 3: 51 - 60 

166. LUMBRERAS H. Strongyloidiasis: 1. Evaluación de la Técnica de Baermann modificada en Copa en el estudio de la strongyloidiasis. Revista Médica Peruana, 1963; 32: 119 - 126. 

167. BEAL C.B., VEINS P., GRANT R. et al. A new technique for sampling duodenal contents. AmJ.Trop. Med. Hyg., 1970; 19: 349 - 352. 

168. GROVE D.I. et al. Algorithms in the diagnosis and management of exotic disease. Journal of Infectious Diseases, 1975; 131: 755 - 758. 

169. PELLETIER L. et al. Diagnosis and evaluation of treatment of chronic strongyloidiasis in ex-prisioners of war. The Journal of Infections Diseases, 1988; 157: 573-576. 

170. ARAKAKI T. et al. Efficacy of agar-plate cultive in detection of Strongyloides stercoralis. Journal of Parásitology, 1990; 76: 425 - 428. 

171. DREYER G., FRENANDEZ-SILVA E., ALVES S. et al. Palterus of detection of Strongyloides stercoralis in stoolspecimens: Implications for diagnosis and clinical trials. Journal of Clinical Microbiology, 1996; 34:2569 -2571. 

172. GENTA R.M. Predictive value of an enzyme-linked immunosorbent assay (ELISA) forthe serodiagnosis of Strongyloidiasis. Am J. Clin. Pathol., 1988; 89: 391 -395. 

173. NEVA F.A., GARN A.A., BURKE J. Comparison of larval antigens in an enzyme-linked immunosorbent assay for strongyloidiasis in humans. J. Infect Dis., 1981; 144: 427 - 432.

174. SATO Y., TAKARA M., OTSURU M. Detection of antibodies in strongyloidiasis by enzyme-linked immunosorbent assay (ELISA). Trans. R. Soc. Trop. Med. Hyg., 1985; 79: 51 - 55. 

175. GAM A.A., NEVA F.A., KROTOSKI W.A. Comparative sensitivity and specifity of ELISA and IHA for serodiagnosis of strongyloidiasis with larvae antigens. Am J. Trop. Med. Hyg., 1987; 37:157 - 161. 

176. GENTAR.M. etal. Antibodies to Strongyloidesstercoralis larval surface antigens in chronic strongyloidiasis. Laboratory Investigation, 1982; 47: 87 - 90. 

177. ARBELAEZ C.A. Diagnóstico serológico de la strongyloidiasis humana por la Técnica de Ensayo Inmunoenzimdtico. Medellin, marzo 1992 - setiembre 1993. Revista CES Medicina, 1994; 8: 7 - 24. 

178. GROVE D.I. Treatment of strongyloidiasis with thiabendazole: ananalysisof toxicity and effectiveness. Trans. R. Soc. Trop. Med. Hyg., 1982; 76: 114 - 118. 

179. SATO Y., KOBAYASHI J., SHIROMAY. Serodiagnosis of strongyloidiasis. The application and significance. Rev. Inst. Med. Trop. Sao Paulo, 1995; 37: 35 - 41. 

180. RAMACHANDRAN S., GAM A.A., NEVA F.A. Molecular differences between several species of Strongyloides and comparison of selected isolates of Strongyloides stercoralis using a Polimerasa chain reactionlinked restriction fragment length polymorphism approach. Am J. Trop. Med. Hyg., 1997; 56: 61 - 65. 

181. CONWAY D.J., UNDO J.F., ROBINSON R.D. et al. Towards effective control of Strongyloides stercoralis. Parásitology Today, 1995; 11: 420 - 423. 

182. WHO model prescribing information: Drugs used in parasitic diseases. Geneva: World Health Organization, 1990. 

183. TOCCO D.J., ROSEMBLUM C., MARTIN C.M. et al. Absortion, metabolism and excretion of Thiabendazole in man and laboratory animals. Toxicol App Pharmacol, 1966; 9: 31 - 39. 

184. GROVE D.I. In Grove D.I. (de.). Strongyloidiasis: A majorroundworm infection of man. London, Taylorand francis, 1989: 199. 

185. BOKEN D.J., LEONI P.A., PREHEIM L.C. Treatmentof Strongyloidesstercoralis Hyperinfection Syndrome with Thiabendazole administered per rectum. Clinical Infec. Diseas., 1993; 16: 123 - 126. 

186. VAN ROS G. La Strongyloidose (anguillulose) importee en Belgique: Incidence, symptomes, diagnostic et traitement. Rev. Med. Liege, 1986; 41: 1004 - 1007. 

187. GROVE D.I., LUMSDEN J., NORTHEM C. Efficacy of albendazol against Strongyloides ratti andStrongyloides stercoralis in vitro, in mice and in normal and immusuppressed dogs. J. Antimicrob. Chernother, 1988; 21: 75 - 80. 

188. ROSSIGNOL J.F., MAISONNEUVE H. Albendazole: Placebo-controlled study in 870 patients with intestinal helminthiasis. Trans. R. Soc. Trop. Med. Hyg., 1983; 77: 707 - 711.

189. MATO V., MORELIZA A.A., CHIARAMELLI M.C. et al. Demarcacao da actividade anti-helmintica do albendazol. Estudio referente a Estrongyloidiase humana. Rev. Inst. Med. Trop. Sao Paulo, 1985; 7: 95 - 98. 

190. DATRY A., HILMARSDOTTIR Y., MAYORGASAGASTUME R. et al. Treatment of Strongyloides stercoralis infection with ivermectin compared with albendazol: results of an open study of 60 cases. Trans. R. Soc. Trop. Med. Hyg., 1994; 88: 344 - 345. 

191. FREEDMAN D.O., ZIERDT W.S., LUJAN A. et al. The efficacy of ivermectin in the chemotherapy of gastrointestinal Helminthiasis in humans. The Journal of Infect. Dis., 1989; 159: 1151 - 1153. 

192. TORRES J.R., ISTURIZ R., MURILLO J. et al. Efficacy of ivermectin in the treatment of Strongyloidiasis complicating AIDS. Clin. Infect. Dis., 1993; 17:900 - 902. 

193. LINDO J.F., ATKINS N.S., LEE M.G. et al. Parasitespecific serum IgG following successful treatment of endemic Strongyloidiasis using ivermective. Trans. R. Soc. Trop. Med. Hyg., 1996; 90: 702 - 703. 

194. SHIKIYA K., KINJO N., UEHARA T. et al. Efficacy of ivermectin against Strongyloides stercoralis in humans. Internal Medicine, 1992; 31(3): 310 - 312. 

195. CAMPBELL W.C., FISH ER M. H., STAPLEY E.O. et al. Ivermectin: a potent new antiparasitic agent. Science, 1983; 221: 823 - 828. 

196. PACQUE M., MUÑOZ N., POETSCHKE G. et al. Inadvertent treatment of pregnant women with ivermectin during a community-based distribution: Pregnancy outcome. Lancet, 1990; 360: 1486 - 1488. 

197. MORGAN J.S., SCHAFFNER W. STONE W.J. Opportunistic Strogyloidiasis in renal transplant recipients. Tranplantation, 1986; 42: 518 - 521.

 

Atrás